Evidence map›Paper›PMID 27194621›Full record

ArticleScientific reports2016

Endocytosis of indium-tin-oxide nanoparticles by macrophages provokes pyroptosis requiring NLRP3-ASC-Caspase1 axis that can be prevented by mesenchymal stem cells.

Abderrahim Naji, Basilua André Muzembo, Ken-Ichi Yagyu, Nobuyasu Baba, Frédéric Deschaseaux, Luc Sensebé, Narufumi Suganuma

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Periodic Table of Immunomodulatory Elements and Derived Two-Dimensional Biomaterials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Nanomaterial-induced pyroptosis: a cell type-specific perspective.Frontiers in cell and developmental biology · 2023
    Review
  10. Nanomedicine-Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Validation of the Anticolitis Efficacy of the Jian-Wei-Yu-Yang Formula.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Abderrahim NajiCenter for Innovative and Translational Medicine (CITM), Kochi Medical School, Kochi University, Kochi, Japan.
Basilua André MuzemboDepartment of Environmental Medicine, Kochi Medical School, Kochi University, Kochi, Japan.
Ken-Ichi YagyuCenter for Innovative and Translational Medicine (CITM), Kochi Medical School, Kochi University, Kochi, Japan.
Nobuyasu BabaCenter for Innovative and Translational Medicine (CITM), Kochi Medical School, Kochi University, Kochi, Japan.
Frédéric DeschaseauxSTROMALab, Université de Toulouse, UMR 5273 CNRS, INSERM U1031, EFS Pyrénées-Méditerranée, Toulouse, France.
Luc SensebéSTROMALab, Université de Toulouse, UMR 5273 CNRS, INSERM U1031, EFS Pyrénées-Méditerranée, Toulouse, France.
Narufumi SuganumaCenter for Innovative and Translational Medicine (CITM), Kochi Medical School, Kochi University, Kochi, Japan.
Kōchi University · JPCentre National de la Recherche Scientifique · FRUniversité de Toulouse · FRUniversity of Kochi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological effects of indium-tin-oxide (ITO) are of considerable importance because workers exposed to indium compounds have been diagnosed with interstitial lung disease or pulmonary alveolar proteinosis; however, the pathophysiology of these diseases is undefined. Here, mice intraperitoneally inoculated with ITO-nanoparticles (ITO-NPs) resulted in peritonitis dependent in NLRP3 inflammasome, with neutrophils recruitment and interleukin-1β (IL-1β) production. Withal peritoneal macrophages exposed ex vivo to ITO-NPs caused IL-1β secretion and cytolysis. Further, alveolar macrophages exposed to ITO-NPs in vitro showed ITO-NP endocytosis and production of tumor necrosis factor-α (TNF-α) and IL-1β, ensued cell death by cytolysis. This cell death was RIPK1-independent but caspase1-dependent, and thus identified as pyroptosis. Endocytosis of ITO-NPs by activated THP-1 cells induced pyroptosis with IL-1β/TNF-α production and cytolysis, but not in activated THP-1 cells with knockdown of NLRP3, ASC, or caspase1. However, exposing activated THP-1 cells with NLRP3 or ASC knockdown to ITO-NPs resulted in cell death but without cytolysis, with deficiency in IL-1β/TNF-α, and revealing features of apoptosis. While, mesenchymal stem cells (MSCs) co-cultured with macrophages impaired both inflammation and cell death induced by ITO-NPs. Together, our findings provide crucial insights to the pathophysiology of respiratory diseases caused by ITO particles, and identify MSCs as a potent therapeutic.

Indexed as

PyroptosisAnimalsCARD Signaling Adaptor ProteinsCaspase 1Cells, CulturedCoculture TechniquesEndocytosisHumansInterleukin-1betaMacrophagesMesenchymal Stem CellsMiceNanoparticlesNeutrophilsNLR Family, Pyrin Domain-Containing 3 ProteinPeritonitisCARD Signaling Adaptor ProteinsCaspase 1indium tin oxideInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePycard protein, mouseReceptors, Cell SurfaceTin Compounds

Identifiers

PMID27194621
PMCPMC4872131
OpenAlexW2406129575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.